---
schema_version: "secwatch.filing_event.v1"
accession: "0000711404-23-000068"
form_type: "8-K"
ticker: "COO"
cik: "0000711404"
company_name: "COOPER COMPANIES, INC."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:35:34.347735+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cooper Q4 revenue $927M (+9%); FY2024 guidance $3.81-3.88B; 4-for-1 stock split

## Summary
- Q4 GAAP diluted EPS $1.70 (+29%); non-GAAP diluted EPS $3.47 (+26%). FY GAAP EPS $5.91 (-24%), non-GAAP $12.81 (+3%).
- CooperVision Q4 revenue $622.9M (+11% YoY) led by toric (+18%) and multifocal (+22%) lenses.
- CooperSurgical Q4 revenue $304.2M (+6%), fertility up 12%.
- FY2024 guidance: revenue $3.809-3.877B; non-GAAP EPS $13.60-14.00.
- Board approved 4-for-1 stock split (effective Feb 16, 2024) and will end de minimis semi-annual dividend.

## SEC filing metadata
- accession: 0000711404-23-000068
- form_type: 8-K
- ticker: COO
- cik: 0000711404
- company_name: COOPER COMPANIES, INC.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711404/000071140423000068/0000711404-23-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711404/000071140423000068/coo-20231206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000711404-23-000068
- JSON: https://secwatch.observer/filing/0000711404-23-000068.json
- Plain text: https://secwatch.observer/filing/0000711404-23-000068.txt

## Key facts
- Earnings Releases
  COOPER COMPANIES, INC. reported fiscal year 2024 results: revenue $3,809 - $3,877 million, EPS $13.60 - $14.00 (non-GAAP diluted EPS). Guidance initiated.
  - Period: fiscal year 2024
  - Revenue: $3,809 - $3,877 million
  - EPS: $13.60 - $14.00 (non-GAAP diluted EPS)
  - Guidance: initiated
  - Result: guidance update
  source text: The Company initiated its fiscal year 2024 financial guidance. Details are summarized as follows: • Fiscal 2024 total revenue of $3,809 - $3,877 million (organic growth of 6% to 8%) • CVI revenue of $2,548 - $2,594 million (organic growth of 7% to 9%) • CSI revenue of $1,261 - $1,283 million (organic growth of 4% to 6%) • Fiscal 2024 non-GAAP diluted earnings per share of $13.60 - $14.00
  evidence_url: https://www.sec.gov/Archives/edgar/data/711404/000071140423000068/0000711404-23-000068-index.htm
- Earnings Releases
  COOPER COMPANIES, INC. reported fiscal 2023 full year ended October 31, 2023 results: revenue $3,593.2 million.
  - Period: fiscal 2023 full year ended October 31, 2023
  - Revenue: $3,593.2 million
  - Result: reported results
  source text: CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023. • Fourth quarter 2023 revenue of $927.1 million, up 9%, and up 9% organically. Fiscal year 2023 revenue of $3.6 billion, up 9%, or up 10% organically. • Fourth quarter 2023 GAAP diluted earnings per share (EPS) of $1.70, up 29%. Fiscal 2023 GAAP diluted EPS of $5.91, down 24%. • Fourth quarter 2023 non-GAAP diluted EPS of $3.47, up 26%. Fiscal 2023 non-GAAP diluted EPS of $12.81, up 3%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/711404/000071140423000068/0000711404-23-000068-index.htm
- Earnings Releases
  COOPER COMPANIES, INC. reported fiscal Q4 2023 ended October 31, 2023 results: revenue $927.1 million, EPS $1.70 (GAAP diluted EPS), $3.47 (non-GAAP diluted EPS).
  - Period: fiscal Q4 2023 ended October 31, 2023
  - Revenue: $927.1 million
  - EPS: $1.70 (GAAP diluted EPS), $3.47 (non-GAAP diluted EPS)
  - Result: reported results
  source text: a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023. • Fourth quarter 2023 revenue of $927.1 million, up 9%, and up 9% organically. Fiscal year 2023 revenue of $3.6 billion, up 9%, or up 10% organically. • Fourth quarter 2023 GAAP diluted earnings per share (EPS) of $1.70, up
  evidence_url: https://www.sec.gov/Archives/edgar/data/711404/000071140423000068/0000711404-23-000068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.